Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ: DXCM )

80.04 +4.22 (+5.57%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
Via The Motley Fool
Peering Into DexCom's Recent Short Interest
Via Benzinga
Key Takeaways From DexCom Analyst Ratings
Via Benzinga
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
Via The Motley Fool
Exploring the Growth Potential of NASDAQ:DXCM as It Nears a Breakout.
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout. 
Via Chartmill
NASDAQ:DXCM qualifies as a high growth stock and is consolidating.
Is DEXCOM INC (NASDAQ:DXCM) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
Analyst Expectations For DexCom's Future
Via Benzinga
These Analysts Revise Their Forecasts On DexCom Following Q3 Results
Via Benzinga
2 Excellent Healthcare Stocks to Hold Through the Next Decade
Via The Motley Fool
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
Via The Motley Fool
2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest
Via The Motley Fool
Large-Cap Stocks In Trouble - Sunday, Nov. 17
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
Via Talk Markets
Tiger Global Hedge Fund Buys Flutter Entertainment Stock, Sells DexCom
Billionaire investor Chase Coleman's hedge fund, Tiger Global Management, filed its latest Form 13F on Thursday and disclosed its trading activity from the prior quarter. 
Via Benzinga
Where Will DexCom Be in 5 Years?
Recent developments might have scared away some investors, but patience could pay off. 
Via The Motley Fool
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024. 
Via Investor's Business Daily
1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years
This medical device company is down but not out. 
Via The Motley Fool
Why DexCom Stock Flopped on Friday
Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth. 
Via The Motley Fool
Nasdaq Up Triple Digits As Stocks Rally, Yields Cool
Stocks are finishing the week strong, but it's a pyrrhic victory, with two of the three major indexes still staring down sizable weekly losses. 
Via Talk Markets
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
The major indexes were mixed for the week. 
Via Investor's Business Daily
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earnings releases from five of the “Magnificent Seven” stocks. 
Via Benzinga
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
DexCom (DXCM) Q3 2024 Earnings Call Transcript
DXCM earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
DexCom Stock Drops After Q3 Results, Announces C-Suite Transition
DexCom reported its third-quarter results after Thursday's closing bell. Here's a look at the details from the report. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Dexcom Tops Quarterly Expectations And Keeps Its Guidance. But Shares Crash.
The company continues to expect 11% to 13% organic sales growth this year. 
Via Investor's Business Daily
Jim Cramer Calls AST SpaceMobile 'Overvalued,' Warns HubSpot Is 'Playing With Fire'
Cheniere Energy (LNG) is a buy, while GE Vernova (GEV) may sell off on good news. HubSpot (HUBS) is risky, NuScale Power (SMR) is losing money, and AST SpaceMobile (ASTS) is overvalued. 
Via Benzinga
Tech Stocks Rebound, Tesla Soars To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Tech Stocks Rebound With Tesla Soaring To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.